Search Result

Results for "

Peptide Delivery

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Amyloid-β (1) Peptide-Drug Conjugates (PDCs) (1) ADC Linker (3) Amino Acid Derivatives (5) Apoptosis (1) Bacterial (10) Biochemical Assay Reagents (96) Collagen (3) Complement System (3) DNA Alkylator/Crosslinker (1) Drug Derivative (7) Drug Intermediate (1) EGFR (4) Exosomes (4) Fluorescent Dye (5) Folate Receptor (FR) (1) HBV (1) HIV (7) Influenza Virus (1) Integrin (11) Interleukin Related (2) LDLR (4) Liposome (158) MHC (1) Microtubule/Tubulin (1) MMP (4) Na+/K+ ATPase (2) nAChR (2) P-selectin (1) Potassium Channel (1) Proteasome (3) PSMA (2) RABV (3) Radionuclide-Drug Conjugates (RDCs) (2) Reference Standards (1) Small Interfering RNA (siRNA) (1) STING (1) TET Protein (2) TMV (1) Transferrin Receptor (2) Transmembrane Glycoprotein (4) VEGFR (1) VSV (1)
By Research Areas:	Cancer (133) Cardiovascular Disease (24) Endocrinology (2) Infection (20) Inflammation/Immunology (27) Metabolic Disease (4) Neurological Disease (30)
Click Chemistry:	DBCO (1) Azide (1)
Oligonucleotides:	Pegylated Lipids (110) Phospholipids (2) Polymers (5)

331

Inhibitors & Agonists

Screening Libraries

Fluorescent Dyes

223

Biochemical Assay Reagents

135

Peptides

MCE Kits

Natural
Products

Click Chemistry

117

Oligonucleotides

Targets Recommended: RXFP Receptor Formyl Peptide Receptor (FPR) Peptide-Drug Conjugates (PDCs) Natriuretic Peptide Receptor (NPR) Connective Peptide CGRP Receptor Amyloid-β

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-166648

DSPE-PEG2000-Maleimide sodium (purity>99%) 1 Publications Verification	Liposome	Cancer
DSPE-PEG2000-Maleimide sodium (purity>99%) is a functional lipid component and a thiol-reactive crosslinker. DSPE-PEG2000-Maleimide sodium (purity>99%) undergoes Michael addition with the thiol groups of thiolated or cyclic RGD peptides to form stable thioether bonds and DSPE-PEG2000-RGD. DSPE-PEG2000-Maleimide sodium (purity>99%) is applicable to research on drug delivery .

HY-P4108

TAT-HA2 Fusion Peptide	Influenza Virus	Infection
TAT-HA2 Fusion Peptide is a peptide-based delivery agent that combines the pH-sensitive HA2 fusion peptide from Influenza and the cell-penetrating peptide TAT from HIV. TAT-HA2 Fusion Peptide is a transactivator of transcription and hemaglutanin for endosomal release. TAT-HA2 Fusion Peptide enhances cellular uptake of macromolecules .

HY-150241

DOPE-NHS	Exosomes Biochemical Assay Reagents Liposome	Others
DOPE-NHS is a linker. DOPE-NHS can be used for peptides to be conjugated to exosomes and possibly other membrane-based nanoparticles. DOPE-NHS can be used for drug delivery .

HY-P10709

CREKA peptide	Collagen	Cardiovascular Disease Cancer
CREKA peptide is a selective non-covalent binding agent targeting fibrin, type IV collagen, and fibronectin, often used as a targeting ligand to modify delivery carriers. CREKA peptide specifically recognizes fibrin, fibronectin, and type IV collagen that are excessively deposited in the tumor microenvironment or fibrotic tissue, mediating the targeted accumulation of the carrier at the lesion site and promoting drug internalization into target cells (such as cancer cells and activated hepatic stellate cells). CREKA peptide can enhance targeted delivery efficiency, increase drug concentration at the lesion site, and reduce systemic side effects .

HY-P4121

L17E	Potassium Channel	Inflammation/Immunology Cancer
L17E is an attenuated cationic amphiphilic lytic (ACAL) peptide that can be used to deliver a variety of macromolecules, including proteins, antibodies, and DNA nanostructures. L17E inserts and cleaves the membrane structure through electrostatic interaction, enabling intracellular escape. The efficiency of L17E-mediated delivery is strongly correlated with the expression level of KCNN4 (the gene encoding the calcium-activated potassium channel KCa3.1). L17E also promotes the cellular uptake of macromolecules by inducing micropinocytosis. L17E can be further optimized and improved through dimerization strategies and in combination with other delivery systems, such as nuclear localization signal peptides and cell membrane-coated nanoparticles .

HY-P10128

GE11 1 Publications Verification	Biochemical Assay Reagents	Inflammation/Immunology
GE11 is a active peptide and combines with colloidal drug delivery systems as smart carriers for antitumor drugs and can be used for cancer study .

HY-P4093

Cys-Penetratin	Biochemical Assay Reagents	Others
Cys-Penetratin is a cysteine-containing cell-penetrating peptide with sequence CRQIKIWFQNRRMKWKK. Cys-Penetratin can Cys-Penetratin can be used for the research for the research of drug delivery .

HY-P11094

Tet1-Cys peptide	TET Protein	Neurological Disease
Tet1-Cys peptide is a peptide with the sequence HLNILSTLWKYRC. Tet1 (HLNILSTLWKYR) (HY-P10998) can specifically bind to the neuronal ganglioside receptor GT1b, possessing neuronal targeting capabilities. The Tet1-Cys peptide sequence has an added Cys, which can be used for drug conjugation for research on drug delivery .

HY-177203

DSPE-PEG2000-APWHLSSQYSRT	Liposome	Cardiovascular Disease
DSPE-PEG2000-APWHLSSQYSRT is a PEG compound which composed of DSPE and 12-amino acid cardiac targeting peptide (APWHLSSQYSRT). DSPE-PEG2000-APWHLSSQYSRT can be used for drug delivery .

HY-P10216

CAQK peptide	Biochemical Assay Reagents	Neurological Disease
CAQK peptide selectively binds to injured mouse brain. CAQK peptide selectively targets demyelinating areas and it is absent from healthy tissue. The CAQK peptide target is a proteoglycan complex upregulated in brain injuries and is used for drug delivery. CAQK peptide can penetrate the blood-brain barrier .

HY-P6022

G4RGDSP, integrin-binding peptide	Integrin	Others
G4RGDSP, Integrin-binding peptide is a cell integrin-binding peptide that targets integrin receptors. G4RGDSP, integrin-binding peptide is coupled to alginate to increase the viability of cells in the scaffold. G4RGDSP, integrin-binding peptide can be used as an extrudable carrier for chondrocyte delivery for the study of 3D printing technology

HY-78736

Val-Cit-PAB-OSBT	ADC Linker	Cancer
Val-Cit-PAB-OSBT is a degradable ADC linker composed of the peptide Val-Cit-PAB and the OSBT group, which ensures stable performance during targeted drug delivery .

HY-166648A

DSPE-PEG-Maleimide ammonium (MW 2000) 1 Publications Verification	Liposome	Others
DSPE-PEG-Maleimide ammonium (MW 2000) is a functional lipid component and a thiol-reactive crosslinker. DSPE-PEG-Maleimide ammonium (MW 2000) undergoes Michael addition with the thiol groups of thiolated or cyclic RGD peptides to form stable thioether bonds and DSPE-PEG (2000)-RGD. DSPE-PEG-Maleimide ammonium (MW 2000) is applicable to research on drug delivery .

HY-P0328

VSV-G tag Peptide 1 Publications Verification	VSV	Infection
VSV-G tag Peptide is a 11 amino acid peptide derived from the Vesicular Stomatitis viral glycoprotein. VSV-G tag Peptide can integrate into the cell membranes of animal cells, induce cell fusion, and significantly enhance the efficiency of DNA transfection into animal cells. VSV-G tag Peptide can be used for research on drug delivery .

HY-P5533

CRT	Biochemical Assay Reagents	Cancer
CRT, an iron peptide mimic, can bind to apo-transferrin (apo-Tf). CRT can be used to modify nanoparticles, and enhances drug delivery efficiency .

HY-P4123

TAT (47-57) GGG-Cys(Npys)	MMP	Cardiovascular Disease Inflammation/Immunology Cancer
TAT (47-57) GGG-Cys (Npys) is a cell-penetrating peptide and delivery carrier derived from TAT. TAT (47-57) GGG-Cys (Npys) facilitates the translocation of conjugated drug molecules across cell membranes. TAT (47-57) GGG-Cys (Npys) acts as a delivery carrier for MT1-MMP inhibitors. TAT (47-57) GGG-Cys (Npys) is applicable to research on diseases associated with MT1-MMP activity, such as cancer, arthritis, heart disease, and vascular disorders .

HY-P4118

EB1 peptide Penetrating analog	Amino Acid Derivatives Peptide-Drug Conjugates (PDCs)	Others
EB1 peptide (Penetrating analog) is an endosomolytic agent and siRNA delivery agent. EB1 peptide forms an amphipathic alpha helix upon protonation in early-late endosomes, drives endosomal membrane permeabilization, and enables endocytosed siRNA escape into the cytosol. EB1 peptide facilitates biologically active siRNA cellular uptake and targeted gene silencing. EB1 peptide forms complexes with siRNA. EB1 peptide can be used for drug delivery research .

HY-P10998

Tet1 peptide	TET Protein	Neurological Disease
Tet1 peptide is a peptide that specifically binds to neurons. Tet1 peptide binds to GT1B ganglioside and trisialoganglioside clostridial toxin receptor on the surface of neuronal cells, and can be used in peptide conjugation and drug delivery research .

HY-P10557

DAG peptide	Biochemical Assay Reagents	Neurological Disease
DAG peptide is a cyclic peptide. DAG peptide selectively recognizes a subset of astrocytes that are activated in Alzheimer's disease (AD) starting at an early stage of the disease. DAG peptide can be used as a tool to enhance the delivery of therapeutics and imaging agents to sites of vascular changes and astrogliosis in diseases associated with neuroinflammation .

HY-P1565

Transdermal Peptide Disulfide TD 1 Disulfide(Peptide)	Na+/K+ ATPase	Inflammation/Immunology
Transdermal Peptide Disulfide (TD 1 Disulfide(peptide)) is a 11-amino acid peptide, binds toNa ⁺/K ⁺-ATPase beta-subunit (ATP1B1), and mainly interacts with the C-terminus of ATP1B1. Transdermal Peptide Disulfide can enhance the transdermal delivery of many macromolecules .

HY-P1565A

Transdermal Peptide Disulfide TFA TD 1 Disulfide(Peptide) TFA	Na+/K+ ATPase	Others
Transdermal Peptide Disulfide TFA (TD 1 Disulfide(peptide) TFA) is a 11-amino acid peptide, binds to Na ⁺/K ⁺-ATPase beta-subunit (ATP1B1), and mainly interacts with the C-terminus of ATP1B1. Transdermal Peptide Disulfide TFA can enhance the transdermal delivery of many macromolecules .

HY-P4083

(Arg)9,TAMRA-labeled	Fluorescent Dye	Others
(Arg)9,TAMRA-labeled is a TAMRA-labeled cell permeable peptide. (Arg)9 is a cell-permeable peptide used for drug delivery .

HY-P10560

M918	Biochemical Assay Reagents	Others
M918 is a cell-penetrating peptide. M918 is internalized by cells through endocytosis and can effectively penetrate a variety of cells in a non-toxic manner. M918 can be used in gene therapy and drug delivery system research .

HY-P3193A

Cyclic nona-L-arginine hydrochloride	Biochemical Assay Reagents	Others
Cyclic nona-L-arginine hydrochloride, a nonaarginine peptide used for drug delivery, translocates faster than their linear counterparts .

HY-P10055A

PSMA targeting peptide TFA 1 Publications Verification PSMA-1 TFA	PSMA	Cancer
PSMA targeting peptide TFA (PSMA-1 TFA) is a PSMA targeting peptide (GRFLTGGTGRLLRIS) and can be used for targeted delivery of glucose-regulated protein (GRP)-silencing siRNAs in PCa cells .

HY-174959D

6-Arm-PEG3400-NHS	Biochemical Assay Reagents	Others
6-Arm-PEG3400-NHS is a six-arm PEG derivative that can be used for peptide modification and drug delivery .

HY-P10895

HR97 TFA	Biochemical Assay Reagents	Others
HR97 TFA is a cell-penetrating peptide that can be combined with engineered melanin to prepare eye drops HR97-SunitiGel. The peptide-drug conjugate in HR97-SunitiGel can provide sustained ocular drug delivery .

HY-172687

DSPE-PEG2000-CSTSMLKAC	Liposome	Cardiovascular Disease
DSPE-PEG2000-CSTSMLKAC is a PEG compound which composed of DSPE and a peptide (CSTSMLKAC). DSPE-PEG2000-CSTSMLKAC can be used for drug delivery DSPE-PEG2000-CSTSMLKAC enables targeted delivery of associated nanoliposomes to ischemic myocardial cells .

HY-P4247

Hexaarginine	Amino Acid Derivatives	Others
Hexa-arginine, consisting of six arginines, is a polycationic peptide that can penetrate cells efficiently and is mainly used for the intracellular delivery of low-molecular-weight agents, biomolecules, and particles .

HY-172473

DSPE-PEG2000-NGR	Liposome	Cancer
DSPE-PEG2000-NGR is a PEG compound which composed of DSPE and an Asn-Gly-Arg (NGR) peptide. NGR peptide can target tumor vascular antigen CD13. DSPE-PEG2000-NGR can be used for drug delivery .

HY-P3402

HBpep-K	Amino Acid Derivatives	Others
HBpep-K is a peptide that can form co aggregated droplets. HBpep-K can efficiently load and deliver small peptides, proteins, and mRNA. HBpep-K can protect mRNA from RNase degradation. HBpep-K is commonly used for drug delivery .

HY-P3402A

HBpep-K acetate	Amino Acid Derivatives	Others
HBpep-K acetate is a peptide that can form co aggregated droplets. HBpep-K acetate can efficiently load and deliver small peptides, proteins, and mRNA. HBpep-K acetate can protect mRNA from RNase degradation. HBpep-K acetate is commonly used for drug delivery .

HY-P11083

Xentry	HBV	Cancer
Xentry is a cell-penetrating peptide (CCP) consisting of only 7 amino acids of hepatitis B virus: LCLRPVG. Xentry-linked anti-B-raf antibodies and siRNAs demonstrates the capability to kill B-raf-dependent melanoma cells. Xentry alone or conjugated to β-galactosidase leads to its delivery to most tissues in mice, except circulating blood cells. Xentry can be used for the delivery of large molecules (antibodies, siRNA, enzymes) .

HY-N15786

DSPE-RGD Lipid sodium	Biochemical Assay Reagents	Cancer
DSPE-RGD Lipid sodium is a lipid containing DSPE and RGD peptides that can be used to prepare lipid nanoparticles for drug delivery.

HY-N15803

DOPE-RGD Lipid sodium	Biochemical Assay Reagents	Cancer
DOPE-RGD Lipid sodium is a lipid containing DOPE and RGD peptides that can be used to prepare lipid nanoparticles for drug delivery.

HY-P11033

Pep2 Peptide	Transmembrane Glycoprotein	Cancer
Pep2 Peptide (also known as scavenger receptor B2) is a peptide ligand for the transmembrane glycoprotein CD36. Pep2 Peptide selectively binds to CD36 over HAS, IgG and CD44. Pep2 Peptide can be studied in research on enhancing delivery of anticancer agent .

HY-W1052262B

Silane-PEG5000-Mal	Biochemical Assay Reagents	Others
Silane-PEG5000-Mal is a PEG derivative that can be used to modify proteins, peptides and other materials. Silane-PEG5000-Mal can be used for peptide modification and drug delivery .

HY-W1048855A

4-Arm PEG5000-SCM	Biochemical Assay Reagents	Others
4-Arm PEG5000-SCM is a multi-arm PEG derivative that can be used for peptide modification and drug delivery .

HY-174959

6-Arm-PEG400-NHS	Biochemical Assay Reagents	Others
6-Arm-PEG400-NHS is a six-arm PEG derivative that can be used for peptide modification and drug delivery .

HY-W1048512A

2-Arm PEG20000-NHS	Biochemical Assay Reagents	Others
2-Arm PEG20000-NHS is a multi-arm PEG derivative that can be used for peptide modification and drug delivery .

HY-W1048512C

2-Arm PEG5000-NHS	Biochemical Assay Reagents	Others
2-Arm PEG5000-NHS is a multi-arm PEG derivative that can be used for peptide modification and drug delivery .

HY-174959B

6-Arm-PEG1000-NHS	Biochemical Assay Reagents	Others
6-Arm-PEG1000-NHS is a six-arm PEG derivative that can be used for peptide modification and drug delivery .

HY-174959E

6-Arm-PEG5000-NHS	Biochemical Assay Reagents	Others
6-Arm-PEG5000-NHS is a six-arm PEG derivative that can be used for peptide modification and drug delivery .

HY-174959A

6-Arm-PEG600-NHS	Biochemical Assay Reagents	Others
6-Arm-PEG600-NHS is a six-arm PEG derivative that can be used for peptide modification and drug delivery .

HY-W1048512B

2-Arm PEG40000-NHS	Biochemical Assay Reagents	Others
2-Arm PEG40000-NHS is a multi-arm PEG derivative that can be used for peptide modification and drug delivery .

HY-P11174

CP05	Exosomes Transmembrane Glycoprotein	Others
CP05 is a peptide that specifically recognizes an exosome surface marker (CD63). CP05 anchors exosomes to target tissues for in vivo delivery of exosomes .

HY-W1048851C

4-Arm-PEG20000-Maleimide 4-Arm-PEG20000-Mal	Biochemical Assay Reagents	Others
4-Arm-PEG20000-Maleimide can be used for site-specific protein and peptide modification and can be used for drug delivery .

HY-P10789

P160 peptide	Microtubule/Tubulin	Cancer
The P160 peptide is a breast cancer-targeting peptide that binds to the keratin 1 (KRT1) receptor on breast cancer cells, with a K_d of approximately 1.1 μM, demonstrating significant potential for targeted drug delivery to breast cancer cells. The P160 peptide enhances the cellular uptake and anticancer activity of the pro-apoptotic antimicrobial peptide MccJ25 (microcin J25). The P160 peptide can be used in cancer research .

HY-150242A

Cbz-Ala-Ala-Asn TFA	Liposome	Others
Cbz-Ala-Ala-Asn TFA is a peptide that designed based on the sequence of the substrate of legumain. Legumain is a cysteine protease. Cbz-Ala-Ala-Asn TFA can be applied as a scaffold for drug delivery .

HY-P2483A

Octaarginine TFA	Proteasome Bacterial	Infection Neurological Disease Cancer
Octaarginine TFA is a cell-penetrating peptide and proteasome inhibitor. Octaarginine TFA exhibits mixed-type inhibition against 20S proteasome chymotrypsin-like, caspase-like, and trypsin-like activities, and inhibits 26S proteasome activity with decreased efficiency. Octaarginine TFA induces ubiquitin-conjugated protein accumulation, mediates HSPG-dependent cellular internalization via macropinocytosis, enhances liposomal cargo uptake and gene delivery. Octaarginine TFA can be used for the research of cervix carcinoma, collagen antibody-induced arthritis, and bacterial infections .

Cat. No.	Product Name

HY-L105S

Peptide Compound Library

826 compounds

Peptides, composed of amino acids, serve as crucial building blocks for proteins and have gained significant attention in drug development over the past decade. The advancements in production, modification, and analytical technologies have led to a surge in the potential applications of peptides in medicine. Peptides offer a number of advantages over small molecule drugs, including: greater target specificity and efficacy, more predictable metabolic profiles, easier delivery to where they are needed in the body, and fewer side effects. Peptides are increasingly appearing in all branches of medicine as components of innovative drugs, imaging agents, diagnostic agents, and other complex drugs such as peptide-drug conjugates. To date, more than 80 peptide drugs have been approved to treat a variety of diseases, including microbial infections, obesity, anti-diabetes, and cancer, as well as to develop cell targeting platforms and improve cell penetration properties.

MCE designs a unique collection of 826 peptide compounds. HY-L105S is a peptide compound library that can be provided with solution form based on HY-L105, and can be applied to peptides-based drug development.

Cat. No.	Product Name

HY-K2016

Protein Transfection Reagent 1 Publications Verification
MCE Protein Transfection Reagent is a cationic lipid mixture for complexation with proteins, peptides, antibodies and other biologically active molecules to allow their direct intracellular delivery.

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-N15871

18:1 DGS-NTA(Ni)	Structural Classification Lipid	Liposome
18:1 DGS-NTA(Ni) is a nickel chelating lipid. 18:1 DGS-NTA(Ni) has high affinity for histidine-tags and can bind histidine tags of recombinant proteins. 18:1 DGS-NTA(Ni) can be used for preparation of liposomes and nanosize multilamellar vesicles (NMVs) which are used in protein and peptide binding studies and antigen delivery .